Last update 11 May 2026

Senti Biosciences Holdings, Inc.

Public Company|California, United States| NASDAQ: SNTI

Overview

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
CAR-NK1
Cell therapy1
Top 5 TargetCount
GPC3(Glypican-3)1

Related

2
Drugs associated with Senti Biosciences Holdings, Inc.
SENTI-301
Target
GPC3
Mechanism
GPC3 inhibitors [+2]
Active Org.
Senti Sub I, Inc.Senti Sub I, Inc. [+1]
Originator Org.
Senti Sub I, Inc.Senti Sub I, Inc.
Active Indication
GPC3 Positive Hepatocellular Carcinoma [+2]
Inactive Indication-
Drug Highest PhaseEarly Phase 1
First Approval Ctry. / Loc.-
First Approval Date-
GC-1103
Target-
Mechanism-
Active Org.
Bluerock Therapeutics, Inc. [+2]
Originator Org.
Senti Sub I, Inc.Senti Sub I, Inc. [+2]
Active Indication-
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Senti Biosciences Holdings, Inc.
NCT06652243
/ RecruitingEarly Phase 1IIT
An Early Clinical Study to Evaluate the Safety and Efficacy of SN301A Cell Injection in the Treatment of Subjects with Glypican-3 (GPC3)-Positive Advanced Hepatocellular Carcinoma
NCT06325748
/ Active, not recruitingPhase 1
SENTI-202-101: A Phase 1, Multicenter, Open-Label Study of SENTI-202, a Selective Off-the-Shelf Logic Gated CAR NK Cell Therapy, in Subjects With CD33 and/or FLT3 Expressing Malignancies
100 Clinical Results associated with Senti Biosciences Holdings, Inc.
Login to view more data
0 Patents (Medical) associated with Senti Biosciences Holdings, Inc.
Login to view more data
100 Deals associated with Senti Biosciences Holdings, Inc.
Login to view more data
100 Translational Medicine associated with Senti Biosciences Holdings, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 06 Aug 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Early Phase 1
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
SENTI-301
 ( GPC3 )		Hepatocellular Carcinoma
More
Clinical
SENTI-101
 ( IL-12R )		Ovarian Epithelial Carcinoma
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free